New company formed around noninvasive brain analysis tool
This article was originally published in Clinica
Executive Summary
A new company has been established by the developers of a system to noninvasively diagnose CNS disorders. Santa Barbara, California-based Izalex will commercialise the NeuroGraph device, which was developed by Thuris, a pharmaceutical company focused on CNS diseases.